ALAN WAGNER, MD
Ophthalmology Physician · NORFOLK, VA
Individual Active NPI 1295719631
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 2,246 | 45,253 | $8,003,144 | $5,309,477 | $4,171,675 |
| 2023 | 2,630 | 38,489 | $7,638,128 | $4,852,184 | $3,810,377 |
| 2022 | 2,419 | 24,405 | $7,160,895 | $4,662,228 | $3,645,338 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 19,800 | $35 | $27 |
| J2782 | Injection, avacincaptad pegol, 0.1 mg | 6,920 | $108 | $86 |
| 92134 | Imaging of retina | 4,181 | $40 | $31 |
| 92014 | Established patient complete exam of visual system | 3,742 | $126 | $90 |
| 67028 | Injection of drug into eye | 2,693 | $132 | $101 |
| J0178 | Injection, aflibercept, 1 mg | 2,132 | $825 | $658 |
| J0177 | Injection, aflibercept hd, 1 mg | 1,704 | $329 | $262 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,576 | $148 | $118 |
| J9035 | Injection, bevacizumab, 10 mg | 1,425 | $72 | $57 |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 294 | $313 | $249 |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 267 | $166 | $116 |
| 92250 | Photography of the retina | 89 | $37 | $28 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | 0101039260 | VA |
| Retina Specialist (Ophthalmology) Physician | 207WX0107X | 0101039260 | VA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Virginia
- NPI 1740469469
- NPI 1154993905
- NPI 1134482466
- NPI 1093244790
- NPI 1760689277
- NPI 1356340830
- NPI 1730490707
- NPI 1770546442
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.